Sionna Therapeutics, Inc.

Healthcare

NASDAQ:SION · NASDAQ Global Market

Market Cap $1.68B Beta 1.29 P/E (TTM) -19.7

$37.30 +1.85%

+$0.68 today

52W Low $13.81High $48.45

Vol 0.60M · Avg 0.39M

EPS (TTM) -$1.90Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+164.54%

Period High

$45.95

Period Low

$14.10

Latest

$37.30

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vera Therapeutics, Inc.

NASDAQ:VERA

$2.51B

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$2.20B

Immunome, Inc.

NASDAQ:IMNM

$1.73B

Zymeworks Inc.

NASDAQ:ZYME

$1.67B

AbCellera Biologics Inc.

NASDAQ:ABCL

$1.66B

Ardelyx, Inc.

NASDAQ:ARDX

$1.43B

Biohaven Ltd.

NYSE:BHVN

$1.42B

Maze Therapeutics, Inc.

NASDAQ:MAZE

$1.39B

Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

$1.21B

Janux Therapeutics, Inc.

NASDAQ:JANX

$851.81M

What is the latest SION filing?

The latest filing shown is 4 dated May 29, 2026.

How many recent filings does SION have?

Intrinsic Alpha currently shows 20 recent filings for SION.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.